Position in NVS
as of Jun 30, 2026
· filed Jul 17, 2026
Position Value
$519,370
+$2,464 QoQ
Shares Held
3,314
-2.1% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.29%
of 13F equity value
Holder Rank
#871
of 1,603 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority
Sole 73%
Shared 0%
None 27%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026ARVEST INVESTMENTS, INC. holds $10,070,233 across 7 Drug Manufacturers - General names. NVS ranks #6 (5.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRK |
Merck & Co., Inc.
|
30,803 | $3,958,185 | |
| 2 | JNJ |
Johnson & Johnson
|
7,022 | $1,783,377 | |
| 3 | ABBV |
AbbVie Inc.
|
6,201 | $1,560,419 | |
| 4 | LLY |
ELI LILLY & Co
|
918 | $1,101,076 | |
| 5 | PFE |
Pfizer Inc
|
31,383 | $755,702 | |
| 6 | NVS |
Novartis AG
This page
|
3,314 | $519,370 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
6,805 | $392,104 |
All Filings in NVS
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $519,370 | 3,314 | Shares | Sole | 2026-07-17 | |
| 2026-03-31 | $516,906 | 3,384 | Shares | Sole | 2026-04-14 | |
| 2025-12-31 | $477,305 | 3,462 | Shares | Sole | 2026-01-20 | |
| 2025-09-30 | $481,028 | 3,751 | Shares | Sole | 2025-10-14 | |
| 2025-06-30 | $458,990 | 3,793 | Shares | Sole | 2025-07-03 | |
| 2025-03-31 | $1,734,071 | 15,555 | Shares | Sole | 2025-04-15 | |
| 2024-12-31 | $1,593,548 | 16,376 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $2,016,875 | 17,535 | Shares | Sole | 2024-11-04 | |
| 2024-06-30 | $2,114,189 | 19,859 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $1,997,087 | 20,646 | Shares | Sole | 2024-04-19 | |
| 2023-12-31 | $2,448,926 | 24,254 | Shares | Sole | 2024-01-24 | |
| No filing history on record for this holder in this stock. | ||||||